My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Cardiovasc Res. 2007 Aug 1;75(3):468-77. Epub 2007 Mar 14.

    CD36 and macrophages in atherosclerosis.

    Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL.

    Cardiovascular Division, King's College, London, UK. sophie.collot@kcl.ac.uk

    Abstract

    CD36 is a multi-ligand scavenger receptor present on the surface of a number of cells such as platelets, monocytes/macrophages, endothelial and smooth muscle cells. Monocyte/macrophage CD36 has been shown to play a critical role in the development of atherosclerotic lesions by its capacity to bind and endocytose oxidized low density lipoproteins (OxLDL), and it is implicated in the formation of foam cells. However, the significance of CD36 in atherosclerosis has recently been called into question by different studies, and therefore its exact role still needs to be clarified. The aim of this article is to carefully review the importance of CD36 as an essential component in the pathogenesis of atherosclerosis.

    PMID: 17442283 [PubMed - indexed for MEDLINE]Free Article

    Supplemental Content

    Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk